
Loading, please wait...

Loading, please wait...

The ongoing research into Long COVID highlights significant concerns regarding women's health. Specifically, clinicians are observing a rise in post-COVID climacteric symptoms, which include worsened hot flashes and poor sleep quality. A recent pilot study investigated these phenomena among women at a specialized sleep clinic. This research compared individuals who previously contracted SARS-CoV-2 with those who remained uninfected, focusing on the clinical severity of their symptoms.
Researchers conducted an analytical, observational, cross-sectional study using a convenience sample of 85 women. Among these participants, 34 had a confirmed history of COVID-19, while 51 served as the control group. The evaluation utilized several validated tools, including the Menopause Rating Scale (MRS), the Pittsburgh Sleep Quality Index (PSQI), and the Kupperman Index. Furthermore, the team collected sociodemographic data and tracked the daily frequency of hot flashes to determine clinical differences.
The study findings suggest that viral infections may leave a lasting impact on the endocrine and neurological systems. Specifically, post-COVID climacteric symptoms often manifest as higher scores on the Menopause Rating Scale compared to non-infected peers. Additionally, patients with prior infection frequently reported diminished sleep quality and increased vasomotor instability. This correlation indicates that the inflammatory response triggered by SARS-CoV-2 might exacerbate existing menopausal transitions. Consequently, healthcare providers in India should maintain a high index of suspicion for worsened climacteric distress in patients with a history of COVID-19.
Recognizing the intersection of viral sequelae and menopause is essential for effective patient management. Notably, the study emphasizes that women post-infection may require more targeted interventions for vasomotor symptoms. Furthermore, addressing sleep hygiene becomes paramount, as the PSQI scores often reflect significant disruption in this cohort. By integrating these findings, doctors can offer more personalized care plans that address both hormonal changes and post-viral recovery.
Yes, clinical observations and pilot studies indicate that women who recovered from COVID-19 report more frequent and intense hot flashes compared to those who were never infected.
Research shows that post-COVID patients often have higher PSQI scores. This indicates poorer sleep quality, increased nighttime awakenings, and greater daytime fatigue compared to controls.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A pilot study examines the clinical impact of prior SARS-CoV-2 infection on sleep quality, hot flashes, and climacteric symptoms in women....
7 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today